Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or original human trial data
PubMed 23125330 · doi:10.3949/ccjm.79a.12010
What was done
This narrative review synthesizes clinical concepts regarding androgen decline in men over age 40, examining symptoms, diagnostic approaches, treatment indications, contraindications, and potential risks and benefits of testosterone replacement therapy.
What was found
The abstract reports no quantitative data or specific numerical outcomes. It notes that unlike female menopause, androgen decline in older men is gradual and produces nonspecific symptoms, making it difficult to establish true deficiency, confirm a cause-and-effect link with physical changes, or predict individual clinical response to testosterone therapy.
Why it matters
It outlines clinical guidance on the diagnosis and therapeutic considerations for testosterone replacement in aging men.
Limits
The publication is a narrative review presenting expert commentary rather than primary empirical data, systematic review methodology, or quantitative risk estimates.
Cited by
- supports Age-related testosterone decline in men is much more gradual than the hormonal changes occurring in women during menopause.